Swedbank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Swedbank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233M	Sell	968,092 -24,016	-2%	-$5.26M	0.2%	87
2026 Q1	$188M	Sell	992,108 -110,866	-10%	-$19.4M	0.2%	95
2025 Q4	$188M	Buy	1,102,974 +28,882	+3%	+$4.43M	0.18%	103
2025 Q3	$142M	Hold	1,074,092	–	–	0.14%	118
2025 Q2	$114M	Sell	1,074,092 -28,051	-3%	-$3.05M	0.13%	132
2025 Q1	$137M	Buy	1,102,143 +100,211	+10%	+$13.1M	0.18%	109
2024 Q4	$123M	Hold	1,001,932	–	–	0.15%	112
2024 Q3	$112M	Hold	1,001,932	–	–	0.14%	122
2024 Q2	$107M	Buy	+1,001,932	New	+$110M	0.14%	120
2024 Q1	–	Sell	-1,030,228	Closed	-$127M	–	648
2023 Q4	$127M	Sell	1,030,228 -93,809	-8%	-$11.7M	0.2%	97
2023 Q3	$145M	Buy	1,124,037 +32,563	+3%	+$4.34M	0.25%	80
2023 Q2	$135M	Buy	1,091,474 +141,448	+15%	+$19M	0.23%	87
2023 Q1	$139M	Buy	950,026 +768,428	+423%	+$114M	0.27%	82
2022 Q4	$28.9M	Buy	181,598 +2,575	+1%	+$377K	0.06%	247
2022 Q3	$23.9M	Buy	179,023 +2,992	+2%	+$455K	0.06%	263
2022 Q2	$27.5M	Buy	176,031 +4,938	+3%	+$760K	0.06%	250
2022 Q1	$26.6M	Buy	171,093 +7,112	+4%	+$1.03M	0.05%	281
2021 Q4	$21M	Buy	163,981 +8,374	+5%	+$1.1M	0.04%	333
2021 Q3	$20.3M	Hold	155,607	–	–	0.04%	337
2021 Q2	$27.6M	Buy	155,607 +12,254	+9%	+$2.12M	0.05%	281
2021 Q1	$23.6M	Buy	+143,353	New	+$23.6M	0.05%	304

Other funds holding JAZZ

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Swedbank's JAZZ Position: Q2 2026 in Review

Swedbank reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.4% in Q2 2026, selling an estimated $5.26M and leaving 968,092 shares worth $233M. The position accounts for 0.2% of the portfolio, ranked #87.

Swedbank first reported a position in JAZZ in Q1 2021 and has held it in 21 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Swedbank held 968,092 shares of Jazz Pharmaceuticals worth $233M as of Q2 2026.
Swedbank sold 24,016 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.26M.
Jazz Pharmaceuticals made up 0.2% of Swedbank's portfolio in Q2 2026, its #87 holding.
Swedbank first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.